The authors measured TNFα serum concentration from metastatic breast cancer patients receiving chemotherapy and found that a serum TNFα concentration of greater than 6.2 pg/mL correlated with a greater than 50% change of breast cancer survival [104]. This evidence concerns the gene TNF and breast carcinoma.